pharma news today obesity drugs glp-1 october 2025 Market The Massachusetts Group Insurance Commission

Other oral compounds like CT-996 / RG 6652 showed a clinically meaningful weight reduction of 6-7% in four weeks among participants without T2D, and GSBR-1290 has demonstrated favourable safety, tolerability and efficacy results

This study demonstrated that the long-acting GLP-1R agonist, NLY01, has different health benefits in two different mouse models of MS

At Pendulum, were passionate about finding revolutionary, safe, and effective solutions to the ailments that can be tied to our gut health

Prescription drugs continue to be a primary driver of employer-sponsored health care costs

read about the other uses of glp1.

Doctor-developed bundle cultivating targeted restoration across the Gut-Metabolic Axis: GLP-1 boosting + Weight Support + Digestive Support + Heart and Circulatory Support + Caffeine-Free Energy